Published 2020-12-01
Keywords
- ST elevation myocardial infarction,,
- reperfusion times,
- ACC/AHA guidelines
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Abstract
Background: New published guidelines recommend treatment of ST elevation myocardial infarction (STEMI) within 30 minutes of first medical contact to thrombolysis and 90 minutes to primary percutaneous coronary intervention (PCI). Objectives: To determine how a tertiary care center compares to these new guidelines and to evaluate the success of measures directed to shorten delays. Methods: This was a prospectively designed audit loop using retrospective chart review. Specific time intervals were evaluated: 1) T2 (ER presentation to diagnostic EKG; 2) T ER (ER presentation to reperfusion); and 3) T AHA (first medical contact to reperfusion). Results of the initial 12-month data were conveyed to Emergency Room staff and a dedicated EKG machine was placed in the ER for the subsequent 12 months, and the results were then re-analyzed. Results: In 2003-4, 58 patients with STEMI were identified, with 41 (70.7%) receiving reperfusion. Of those receiving thrombolysis, median T AHA was 54 [37-72] minutes, with 12.0% <30 minutes, while those receiving PCI, median T AHA was 58 [43-78] minutes, with 25.0% <90 minutes. In 2004-5, 52 patients had STEMI, with 40 (76.9%) receiving reperfusion. The percentage of patients meeting the guidelines was 14.3% for the thrombolysis group and 11.1% for the PCI group. Introduction of a dedicated EKG machine led to a strong trend towards improvement in median T2 (22 vs 10 minutes; P=0.07), but other treatment times remained unchanged. Conclusions: Treatment times are longer than recommended guidelines. More comprehensive strategies and improved coordination of medical services are required to shorten pre-contact and post-contact response times.
Downloads
References
- Tu JV, Austin PC, Filate WA, Johansen HL, Brien SE, Pilote L, Alter DA. Outcomes of acute myocardial infarction in Canada.
- Can J Cardiol 2003; 19(8):893-901.
- Guppo Italiano per lo studio della streptochinasi nell'infarcto miocardia (GISSI investigators). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1:397-402.
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2:349-360.
- The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial
- infarction. N Engl J Med 1993; 329:673-682.
- Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute
- myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343:311-322.
- Grines CL, Browne KF, Marco J et al. for the Primary angioplasty in Myocardial Infarction (PAMI) Study Group. A
- comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328:673-679.
- Anderson HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. (DANAMI-2 Investigators). A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction. N Engl J Med 2003; 349(8):733-742.
- Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial
- infarction: a quantitative review of 23 randomized trials. Lancet 2003; 361:13-20.
- Nallamothu BK, Bates ER. Percutaneous coronary intervention versus Fibrinolytic Therapy in Acute Myocardial Infarction: Is Timing (Almost) Everything?. Am J Cardiol 2003; 92:824-826.
- Giugliano RP, Braunwald E. Selecting the Best Reperfusion Strategy in ST-Elevation Myocardial Infarction: It's All a Matter of Time. Circulation 2003; 108:2828-30.
- Gersh BJ, Stone GW, White HD, Holmes DR. Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Is the Slope of the Curve the Shape of the Future? JAMA 2005; 293:979-986.
- ACC/AHA Guidelines for the Management of Patients with STElevation Myocardial Infarction: Executive Summary. J Am
- Coll Cardiol 2004; 44:671-719.
- Armstrong PW, Bogarty P, Buller CE, Dorian P, O'Neill BJ. The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. Can J Cardiol 2004; 20(11):1075-9.
- 1999 Update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations. Circ 1999; 100:1016-30.
- Interactive Resources and On-line Material. Department of Quantitative Psychology, University of Kansas.
- http://www.quantpsy.org/ (August 10, 2006).
- Vassar Stats: Website for Statistical Computation. Richard Lowry, Vassar College. http://faculty.vassar.edu/lowry/wilcoxan.html/ (1998-2006).
- Bhagirath KM, Kass M, Chochinov AH, Avery L, Hall L, Tam JW. Prompt treatment of STEMI: A Race Against the Clock. Can J Cardiol 2005; 21 Supplement C: Abstract 491, 166C.
- Davies C, Christenson J, Campbell A, Cox JL, Huynh T, Matheson S et al. FASTRAK II Network. Fibrinolytic therapy in acute myocardial infarction: Time to treatment in Canada. Can J Cardiol 2004; 20(8):801-805.
- Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S, Afilalo M et al. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMIQuebec Study. CMAJ 2006; 175(12):1527-32.
- Kereiakes DJ, Weaver WD, Anderson JL, Feldman T, Gibler B, Aufderheide T et al. Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities: Report from the Pre-hospital Study Group and the Cincinnati Heart Project. Am Heart J 1990; 120:773-780.
- De Villiers JS, Anderson T, McMeekin JD, Leung RCM, Traboulsi M. Expedited transfer for primary percutaneous
- coronary intervention: a program evaluation. CMAJ 2007; 176(13):1833-8.
- Hedges JR, Feldman HA, Bittner V, Goldberg RJ, Zapka J, Osganian SK, et al. the REACT Study Group. Impact of
- Community Intervention to Reduce Patient Delay Time on Use of Reperfusion Therapy for Acute Myocardial Infarction: Rapid Early Action for Coronary Treatment (REACT) Trial. Acad Emerg Med 2000; 7:862-872.
- Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY et al. CAPTIM Study Group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomized study. Lancet 2002; 360:825-829.
- Armstrong PW, WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary
- intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early
- ST-elevation myocardial infarction Therapy) study. European Heart Journal 2006; 27:1530-1538.
- Bjorklund E, Stenestrand U, Lindback J, Svensson L, Wallentin L, Lindahl B, RIKS-HIA Investigators. Pre-hospital
- thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. European Heart Journal 2006; 27:1146-1152.
- Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and Prehospital Thrombolysis for Acute
- Myocardial Infarction: A Meta-analysis. JAMA 2000;283(20):2686-2692.